About Turning Point Therapeutics
We officially combined with Bristol Myers Squibb to advance our precision oncology platform for patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for cancer patients.
For more information on the acquisition, read our press release at: bit.ly/3Uccbu8
|
|
|
11-50 employees
View all Turning Point Therapeutics employees
|
|
Biotechnology
|
|
10628 Science Center Drive, Ste. 200, San Diego, CA 92121, US
|
|
2013
|
|
Oncology, Precision Medicine, Drug Resistance, Structure-Based Design, Nsclc, Src, Alk, Ros1, Fak, Metastasis, G1202R, G2032R, Jak2, Masc, Ntrk, Ntrk1, Ntrk2, Ntrk3, Fusion Gene, Oncogenic
|
Turning Point Therapeutics Alternatives
Frequently Asked Questions about Turning Point Therapeutics
Who are the decision makers in Turning Point Therapeutics?
The decision makers in Turning Point Therapeutics are Carla Taub, Chun Yang, Miriam Cruz, etc. Click to Find Turning Point Therapeutics decision makers emails.
Turning Point Therapeutics Staff Directory
Search Turning Point Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
